China Jo Ownership

CJJD Stock  USD 2.90  0.26  9.85%   
China Jo Jo Drugstores shows 11.33 percent of its outstanding shares held by insiders and 0.48 percent owned by other corporate entities.
 
Shares in Circulation  
First Issued
2007-09-30
Previous Quarter
1.7 M
Current Value
1.2 M
Avarage Shares Outstanding
2.2 M
Quarterly Volatility
5.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as China Jo in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of China Jo, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 9.95. The current year's Common Stock Shares Outstanding is expected to grow to about 814.8 K, whereas Net Loss is projected to grow to (18.1 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Jo Jo Drugstores. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

China Stock Ownership Analysis

The company has price-to-book (P/B) ratio of 0.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. China Jo Jo recorded a loss per share of 4.4. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 1st of March 2024. China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the Peoples Republic of China. The company was founded in 2003 and is headquartered in Hangzhou, the Peoples Republic of China. China Jojo operates under Healthcare Products classification in the United States and is traded on NASDAQ Exchange. For more info on China Jo Jo Drugstores please contact Lei Liu at 86 57 1880 77078 or go to https://www.jiuzhou-drugstore.com.
Besides selling stocks to institutional investors, China Jo also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different China Jo's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align China Jo's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

China Jo Quarterly Liabilities And Stockholders Equity

94.77 Million

About 11.0% of China Jo Jo Drugstores are currently held by insiders. Unlike China Jo's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against China Jo's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of China Jo's insider trades

China Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as China Jo is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading China Jo Jo Drugstores backward and forwards among themselves. China Jo's institutional investor refers to the entity that pools money to purchase China Jo's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Renaissance Technologies Corp2023-12-31
44.4 K
Hillhouse Capital Advisors, Ltd.2024-03-31
20.2 K
Level Four Advisory Services, Llc2023-12-31
16.3 K
Xtx Topco Ltd2023-12-31
15 K
Two Sigma Securities, Llc2023-12-31
14.7 K
Ubs Group Ag2023-12-31
5.5 K
Advisor Group Holdings, Inc.2023-12-31
15.0
Susquehanna International Group, Llp2023-12-31
0.0
Wells Fargo & Co2023-12-31
0.0
Virtu Financial Llc2024-03-31
0.0
Note, although China Jo's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

China Jo Jo Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific China Jo insiders, such as employees or executives, is commonly permitted as long as it does not rely on China Jo's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases China Jo insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

China Jo Corporate Filings

6K
31st of May 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
12th of March 2024
Other Reports
ViewVerify
20th of December 2023
Other Reports
ViewVerify
26th of September 2023
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in China Stock

When determining whether China Jo Jo is a strong investment it is important to analyze China Jo's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact China Jo's future performance. For an informed investment choice regarding China Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Jo Jo Drugstores. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Jo. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Jo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.40)
Revenue Per Share
155.543
Quarterly Revenue Growth
0.08
Return On Assets
(0.12)
Return On Equity
(1.09)
The market value of China Jo Jo is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Jo's value that differs from its market value or its book value, called intrinsic value, which is China Jo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Jo's market value can be influenced by many factors that don't directly affect China Jo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Jo's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Jo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Jo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.